Stabilized HIV-1 Envelope Glycoprotein Trimers Lacking the V1V2 Domain, Obtained by Virus Evolution

被引:21
作者
Bontjer, Ilja
Melchers, Mark
Eggink, Dirk
David, Kathryn [2 ]
Moore, John P. [2 ]
Berkhout, Ben
Sanders, Rogier W. [1 ,2 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, Lab Expt Virol,Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands
[2] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA
基金
美国国家卫生研究院;
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODY; INTERMOLECULAR DISULFIDE BOND; CD4; BINDING-SITE; TYPE-1; ENVELOPE; NEUTRALIZING ANTIBODIES; GP120; GLYCOPROTEIN; MOLECULAR CLONES; PARTIAL DELETION; VARIABLE LOOPS;
D O I
10.1074/jbc.M110.156588
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The envelope glycoproteins (Env) are the focus of HIV-1 vaccine development strategies based on the induction of humoral immunity, but the mechanisms the virus has evolved to limit the induction and binding of neutralizing antibodies (NAbs) constitute substantial obstacles. Conserved neutralization epitopes are shielded by variable regions and carbohydrates, so one strategy to increase their exposure and, it is hoped, their immunogenicity is to delete the overlying variable loops. However, deleting the variable regions from Env trimers can be problematic, because hydrophobic patches that are normally solvent-inaccessible now become exposed, causing protein misfolding or aggregation, for example. Here, we describe the construction and characterization of recombinant gp140 trimers lacking variable domains 1 and 2 (Delta V1V2). The design of the trimers was guided by HIV-1 evolution studies that identified compensatory changes in V1V2-deleted but functional Env proteins (Bontjer, I., Land, A., Eggink, D., Verkade, E., Tuin, K., Baldwin, C., Pollakis, G., Paxton, W. A., Braakman, I., Berkhout, B., and Sanders, R. W. (2009) J. Virol. 83, 368-383). We now show that specific compensatory changes improved the function of Delta V1V2 Env proteins and hence HIV-1 replication. The changes acted by reducing the exposure of a hydrophobic surface either by replacing a hydrophobic residue with a hydrophilic one or by covering the surface with a glycan. The compensatory changes allowed the efficient expression of well folded, soluble gp140 trimers derived from various HIV-1 isolates. The evolved Delta V1V2 Env viruses were extremely sensitive to NAbs, indicating that neutralization epitopes are well exposed, which was confirmed by studies of NAb binding to the soluble Delta V1V2 gp140 trimers. These evolved Delta V1V2 trimers could be useful reagents for immunogenicity and structural studies.
引用
收藏
页码:36456 / 36470
页数:15
相关论文
共 87 条
[1]   SYNERGISTIC INHIBITION OF HIV-1 ENVELOPE-MEDIATED CELL-FUSION BY CD4-BASED MOLECULES IN COMBINATION WITH ANTIBODIES TO GP120 OR GP41 [J].
ALLAWAY, GP ;
RYDER, AM ;
BEAUDRY, GA ;
MADDON, PJ .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (07) :581-587
[2]   The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling [J].
Arnold, K ;
Bordoli, L ;
Kopp, J ;
Schwede, T .
BIOINFORMATICS, 2006, 22 (02) :195-201
[3]   The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region [J].
Barnet, SW ;
Lu, S ;
Srivastava, I ;
Cherpelis, S ;
Gettie, A ;
Blanchard, J ;
Wang, S ;
Mboudjeka, I ;
Leung, L ;
Lian, Y ;
Fong, A ;
Buckner, C ;
Ly, A ;
Hilt, S ;
Ulmer, J ;
Wild, CT ;
Mascola, JR ;
Stamatatos, L .
JOURNAL OF VIROLOGY, 2001, 75 (12) :5526-5540
[4]   Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1 [J].
Beddows, S ;
Schülke, N ;
Kirschner, M ;
Barnes, K ;
Franti, M ;
Michael, E ;
Ketas, T ;
Sanders, RW ;
Maddon, PJ ;
Olson, WC ;
Moore, JP .
JOURNAL OF VIROLOGY, 2005, 79 (14) :8812-8827
[5]   Construction and characterization of soluble, cleaved, and stabilized trimeric Env proteins based on HIV type 1 Env subtype A [J].
Beddows, Simon ;
Kirschner, Marc ;
Campbell-Gardener, Lila ;
Franti, Michael ;
Dey, Antu K. ;
Iyer, Sai Prasad N. ;
Maddon, Paul J. ;
Paluch, Maciej ;
Master, Aditi ;
Overbaugh, Julie ;
VanCott, Thomas ;
Olson, William C. ;
Moore, John P. .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2006, 22 (06) :569-579
[6]   Role of Complex Carbohydrates in Human Immunodeficiency Virus Type 1 Infection and Resistance to Antibody Neutralization [J].
Binley, James M. ;
Ban, Yih-En Andrew ;
Crooks, Emma T. ;
Eggink, Dirk ;
Osawa, Keiko ;
Schief, William R. ;
Sanders, Rogier W. .
JOURNAL OF VIROLOGY, 2010, 84 (11) :5637-5655
[7]   Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins [J].
Binley, JM ;
Sanders, RW ;
Master, A ;
Cayanan, CS ;
Wiley, CL ;
Schiffner, L ;
Travis, B ;
Kuhmann, S ;
Burton, DR ;
Hu, SL ;
Olson, WC ;
Moore, JP .
JOURNAL OF VIROLOGY, 2002, 76 (06) :2606-2616
[8]   A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure [J].
Binley, JM ;
Sanders, RW ;
Clas, B ;
Schuelke, N ;
Master, A ;
Guo, Y ;
Kajumo, F ;
Anselma, DJ ;
Maddon, PJ ;
Olson, WC ;
Moore, JP .
JOURNAL OF VIROLOGY, 2000, 74 (02) :627-643
[9]   GlyProt:: in silico glycosylation of proteins [J].
Bohne-Lang, A ;
von der Lieth, CW .
NUCLEIC ACIDS RESEARCH, 2005, 33 :W214-W219
[10]   Optimization of Human Immunodeficiency Virus Type 1 Envelope Glycoproteins with V1/V2 Deleted, Using Virus Evolution [J].
Bontjer, Ilja ;
Land, Aafke ;
Eggink, Dirk ;
Verkade, Erwin ;
Tuin, Kiki ;
Baldwin, Chris ;
Pollakis, Georgios ;
Paxton, William A. ;
Braakman, Ineke ;
Berkhout, Ben ;
Sanders, Rogier W. .
JOURNAL OF VIROLOGY, 2009, 83 (01) :368-383